Add to ORKGThis is an Open Access article distributed under the terms of the Creative Commons Attribution Licens
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
Parkinson’s disease (PD) is characterized by degeneration of dopaminergic cells, which results in do...
Parkinson’s disease (PD) is characterized by degeneration of dopaminergic cells, which results in do...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(104) / BLDSC - British Libra...
Paolo Solla, Antonino Cannas, Francesco Marrosu, Maria Giovanna MarrosuMovement Disorders Center, In...
Parkinson disease (PD) is a neurodegenerative disorder characterized by 3 cardinal motor symptoms: r...
Parkinson disease (PD) is a neurodegenerative disorder characterized by 3 cardinal motor symptoms: r...
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinso...
Introduction: Parkinson’s disease in its advanced stage is a progressive condition that can be treat...
Levodopa/carbidopa and entacapone in the treatment of Parkinson’s disease: effi cacy, safety and pat...
The aim of this study was to evaluate the efficacy of the new optimised levoclopa, Stalevo(R) (levoc...
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
The Author(s) 2015. This article is published with open access at Springerlink.com Background and Ob...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
Parkinson’s disease (PD) is characterized by degeneration of dopaminergic cells, which results in do...
Parkinson’s disease (PD) is characterized by degeneration of dopaminergic cells, which results in do...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(104) / BLDSC - British Libra...
Paolo Solla, Antonino Cannas, Francesco Marrosu, Maria Giovanna MarrosuMovement Disorders Center, In...
Parkinson disease (PD) is a neurodegenerative disorder characterized by 3 cardinal motor symptoms: r...
Parkinson disease (PD) is a neurodegenerative disorder characterized by 3 cardinal motor symptoms: r...
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinso...
Introduction: Parkinson’s disease in its advanced stage is a progressive condition that can be treat...
Levodopa/carbidopa and entacapone in the treatment of Parkinson’s disease: effi cacy, safety and pat...
The aim of this study was to evaluate the efficacy of the new optimised levoclopa, Stalevo(R) (levoc...
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
The Author(s) 2015. This article is published with open access at Springerlink.com Background and Ob...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
Parkinson’s disease (PD) is characterized by degeneration of dopaminergic cells, which results in do...
Parkinson’s disease (PD) is characterized by degeneration of dopaminergic cells, which results in do...